For example, two recent studies demonstrated that intensive glucose control failed to improve survival and outcomes of macrovascular complications in the first 10 years in patients with diabetes, and that insulin-related morbidity and mortality increased with higher insulin doses and decreased with concomitant metformin treatment (4, 7). The gene discussed is INS; the disease is diabetes mellitus.